ASPIC

envie a um amigo share this

3rd international Conference “Cancer Stem Cells – Impact on Treatment”

Krumers Alpin Resort & Spa in Seefeld, Tyrol, Austria

 

13-17 December, 2020

 

See more informations here: https://www.csc-conference.at/

16th European Congress on Digital Pathology (ECDP 2020)

Edifício da Alfândega, Porto, Portugal

 

13-15 May, 2020

 

See more informations here: http://ecdp2020.org/

16th European Congress on Digital Pathology (ECDP 2020)

Edifício da Alfândega, Porto, Portugal

 

13-15 May, 2020

 

See more informations here: http://ecdp2020.org/

6th World Congress on Controversies in Breast Cancer (CoBrCa)

Mercure Hotel MOA Berlin, Germany

 

November 19-21, 2020

 

See more informations here: https://cobrca.org/

6th World Congress on Controversies in Breast Cancer (CoBrCa)

Mercure Hotel MOA Berlin, Germany

 

November 19-21, 2020

 

See more informations here: https://cobrca.org/

Current challenges and emerging opportunities of CAR-T cell therapies

During the past few years, the establishment of immunotherapy (e.i. stimulation of the immune system to recognize and kill malignant cells) as a reliable therapeutic option to tackle cancer, has shifted the paradigm of cancer treatment. Among the different classes of cancer immunotherapies, including checkpoint inhibitor monoclonal antibodies (2018 Nobel Prize Physiology or Medicine), adoptive T cell therapies (ACTs), harboring CAR-T cells, are emerging as a revolutionary strategy to eliminate tumors.

As células CAR-T no combate ao cancro - desafios atuais e oportunidades futuras

O estabelecimento da imunoterapia - estimulação do sistema imunitário para que este reconheça e destrua as células tumorais - como uma abordagem terapêutica eficaz no combate ao cancro, é, indubitavelmente, um dos maiores marcos no tratamento das doenças oncológicas dos últimos anos.

XXVII Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation

XXVII Porto Cancer Meeting - Stemness & Metastasis: Advances in Research and Clinical Translation

RKIP as an inflammatory and immune system modulator: implications in cancer

Authors and Affiliations:

Maria Gabriela-Freitas 1,2#, Joana Pinheiro 1,2#, Ana Raquel-Cunha 1,2, Diana Cardoso-Carneiro 1,2 and Olga Martinho 1,2,3

1 Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal

2 ICVS/3Bs-PT Government Associate Laboratory, 4710-057 Braga/4805-017 Guimarães, Portugal